Alkem Laboratories share news and announcements
NSE: ALKEMBSE: 539523Pharmaceuticals & BiotechnologyMid Cap
Share price at the NSE close on 23 Oct 2026. Previous close ₹5,013.50.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹59,149 Cr164th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 14 Aug 2026
- 27.4
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 28 May 2026
- 4.3
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.07%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- 16.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- 16.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 28 May 2026
- 0.11
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 54,98251.0% delivered
Alkem Laboratories share news and announcements
793 announcements, routine notices left out, newest first. Page 8 of 16.
Sep 2023
14 Sep · Updates
12 Sep · Analysts
7 Sep · Analysts
7 Sep · Meeting
6 Sep · Analysts
Aug 2023
31 Aug · Analysts
31 Aug · Analysts
25 Aug · Amendment to AOA/MOA
25 Aug · Analysts
17 Aug · Analysts
11 Aug · Analysts
10 Aug · Updates
10 Aug · Board meeting
Jul 2023
31 Jul · Analysts
20 Jul · Updates
Jun 2023
28 Jun · Analysts
28 Jun · Analysts
26 Jun · Analysts
23 Jun · Analysts
14 Jun · Analysts
13 Jun · Analysts
6 Jun · Analysts
2 Jun · Analysts
May 2023
30 May · Analysts
19 May · Business
19 May · Amendment to AOA/MOA
19 May · Corporate action
19 May · Board meeting
9 May · Analysts
Apr 2023
Mar 2023
27 Mar · Analysts
23 Mar · Analysts
20 Mar · Analysts
20 Mar · Analysts
10 Mar · Analysts
9 Mar · Analysts
2 Mar · Analysts
Feb 2023
27 Feb · Analysts